JP2022546703A5 - - Google Patents
Info
- Publication number
- JP2022546703A5 JP2022546703A5 JP2022513237A JP2022513237A JP2022546703A5 JP 2022546703 A5 JP2022546703 A5 JP 2022546703A5 JP 2022513237 A JP2022513237 A JP 2022513237A JP 2022513237 A JP2022513237 A JP 2022513237A JP 2022546703 A5 JP2022546703 A5 JP 2022546703A5
- Authority
- JP
- Japan
- Prior art keywords
- oxytocin
- pharmaceutical composition
- composition according
- thickening agent
- individual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962893363P | 2019-08-29 | 2019-08-29 | |
| US62/893,363 | 2019-08-29 | ||
| PCT/US2020/048736 WO2021042029A1 (en) | 2019-08-29 | 2020-08-31 | Oxytocin compositions for treatment of tinnitus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022546703A JP2022546703A (ja) | 2022-11-07 |
| JP2022546703A5 true JP2022546703A5 (enExample) | 2023-09-11 |
Family
ID=74680528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513237A Ceased JP2022546703A (ja) | 2019-08-29 | 2020-08-31 | 耳鳴りの治療のためのオキシトシン組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11241477B2 (enExample) |
| EP (1) | EP4021410A4 (enExample) |
| JP (1) | JP2022546703A (enExample) |
| AU (1) | AU2020335930B2 (enExample) |
| BR (1) | BR112022003687A2 (enExample) |
| CA (1) | CA3152988A1 (enExample) |
| WO (1) | WO2021042029A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4299059A1 (en) | 2022-07-01 | 2024-01-03 | Labelic Analysis, S.L. | Composition for the treatment of tinnitus |
| US20250255930A1 (en) * | 2024-02-08 | 2025-08-14 | Maskbegone Llc | Methods of treatment of tinnitus using derivatives of oxytocin |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5276982B2 (ja) * | 2005-08-26 | 2013-08-28 | ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ | オキシトシンの投与による頭痛の処置のための方法 |
| EP2167040A1 (en) * | 2007-06-07 | 2010-03-31 | MDRNA, Inc. | Intranasal carbetocin formulations and methods for the treatment of autism |
| WO2011140608A1 (en) | 2010-05-14 | 2011-11-17 | Keating Charlotte L | Neuropsychopharmacological treatment regimes for treating psychological disorders |
| WO2011146726A1 (en) * | 2010-05-19 | 2011-11-24 | The University Of North Carolina At Chapel Hill | Methods and formulations for oxytocin treatment of substance use, psychiatric and other disorders |
| EP2680913B1 (en) | 2011-03-03 | 2020-05-06 | Impel NeuroPharma Inc. | Nasal drug delivery device |
| CN107376071B (zh) | 2011-05-09 | 2021-07-09 | 英倍尔药业股份有限公司 | 用于将化合物递送到使用者的上部嗅觉区的喷嘴 |
| US20140066373A1 (en) | 2012-08-29 | 2014-03-06 | Albert Einstein College Of Medicine Of Yeshiva University | Treating diabetes with oxytocin or oxytocin analogs |
| US11744838B2 (en) * | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
| ES2949052T3 (es) * | 2014-11-19 | 2023-09-25 | Optinose Inc | Administración intranasal |
| PL3242676T3 (pl) | 2015-01-07 | 2024-07-15 | Tonix Pharma Limited | Preparaty oksytocyny zawierające magnez i sposoby ich stosowania |
-
2020
- 2020-08-31 US US17/007,518 patent/US11241477B2/en active Active
- 2020-08-31 JP JP2022513237A patent/JP2022546703A/ja not_active Ceased
- 2020-08-31 WO PCT/US2020/048736 patent/WO2021042029A1/en not_active Ceased
- 2020-08-31 BR BR112022003687A patent/BR112022003687A2/pt unknown
- 2020-08-31 AU AU2020335930A patent/AU2020335930B2/en active Active
- 2020-08-31 CA CA3152988A patent/CA3152988A1/en active Pending
- 2020-08-31 EP EP20856513.5A patent/EP4021410A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI4279070T3 (fi) | Koostumus sisältäen 5-metoksi-N,N-dimetyylitryotamini-bentsoaattisuolaa | |
| TWI496594B (zh) | 噴灑用凝膠型皮膚及/或黏膜附著型製劑及使用該製劑之投藥系統 | |
| US9132243B2 (en) | Method of administering a substance to the throat | |
| JP2021181493A5 (ja) | クロモリンを含む粉末組成物 | |
| EA200802012A1 (ru) | Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением | |
| JP6762931B2 (ja) | 経鼻組成物と該経鼻組成物の使用方法の改善 | |
| JP2024501919A5 (enExample) | ||
| JP2009528337A (ja) | ネブライザー処方物 | |
| JP2023523557A5 (enExample) | ||
| US20050042174A1 (en) | Combined doses | |
| MX2020007745A (es) | Administracion de dosis elevadas de terapias inhaladas. | |
| RU2018143564A (ru) | Карбоновая кислота, предназначенная для лечения/предупреждения заложенности носа | |
| SE0303091L (sv) | Kombinerade doser av tiotropium och fluticason | |
| US10383883B2 (en) | Treatment of congestion using steroids and adrenergics | |
| MX2025003199A (es) | Inhalador de capsula para la administracion de un inhibidor de fosfodiesterasa-4 | |
| WO2023235267A3 (en) | Nintedanib and nintedanib combination dry powder compositions and uses | |
| RU2020112519A (ru) | Ингалятор и сетка для ингалятора | |
| MX2025003202A (es) | Inhalador de capsula para la administracion de un inhibidor de fosfodiesterasa-4 | |
| EP1843750B1 (en) | Nebulizer formulation | |
| AU2020103517A4 (en) | Ibp- nebulizer: intelligent nebulizer for bronchitis patients | |
| US20050042175A1 (en) | Combined doses of formoterol and budesonide | |
| SE0301816D0 (sv) | Combined doses | |
| CN117899164B (zh) | 新型雾化剂型系统及其在药物制备中的应用 | |
| RU2437676C1 (ru) | Противовирусное средство - капли в нос | |
| MX2025003198A (es) | Inhalador de capsula para la administracion de un inhibidor de fosfodiesterasa-4 |